BIO-TECHNE Corp — Director's Dealing 2011

May 31, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2011-05-26

Reporting Person: VERONNEAU MARCEL (VP Hematology Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-05-26	Common Stock	M	505	$40.47	Acquired	35074	Direct
2011-05-26	Common Stock	S	505	$81.196	Disposed	34569	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-05-26	Stock Option	$40.47	M	505	Disposed	2011-07-08	Common Stock (505)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6702	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$58.4	2017-07-29	Common Stock (1281)	1281	Direct
Stock Option	$66.25	2017-04-29	Common Stock (10000)	10000	Direct
Stock Option	$62.46	2016-07-23	Common Stock (494)	494	Direct
Stock Option	$79.41	2015-07-24	Common Stock (385)	385	Direct
Stock Option	$56.83	2014-07-26	Common Stock (510)	510	Direct
Stock Option	$49.43	2013-07-27	Common Stock (567)	567	Direct
Stock Option	$51.6	2012-08-17	Common Stock (475)	475	Direct

Footnotes

F1: Vested 5,000 each 4/30/11 and 4/30/12.